SCHEMBL4413144

SCHEMBL4413144

NC(=O)Cn1c(=O)oc2cc(F)ccc21

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.64
IDO1 P14902 4/20 0.52
CBX7 O95931 5/20 0.49
CDYL Q9Y232 5/20 0.49
CDYL2 Q8N8U2 4/20 0.49
CDY1; CDY1B Q9Y6F8 3/20 0.49
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 1/20 0.48
PKM P14618 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 1/20 0.47
TNIK Q9UKE5 1/20 0.46
CD74 P04233 1/20 0.45
MIF P14174 1/20 0.45
POLB P06746 2/20 0.44
ALPG P10696 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16601597 0.82 HPGD (0.64) HPGDMEN1KMT2APKMSMN1; SMN2
SCHEMBL4411794 0.82 HPGD (0.64) HPGDCBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL4414360 0.82 HPGD (0.64) HPGDIDO1MEN1KMT2APOLB
SCHEMBL4416757 0.82 HPGD (0.59) HPGDIDO1CBX7CDYLCDYL2
SCHEMBL3047009 0.81 CD74 (0.49) IDO1CBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL17096830 0.80 TDO2 (0.52) HPGDIDO1CBX7CDYLCDYL2
SCHEMBL17097162 0.80 TNIK (0.49) HPGDIDO1CBX7CDYLCDYL2
SCHEMBL4413088 0.79 HPGD (0.59) HPGDCBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL13340920 0.79 HPGD (0.59) HPGDCBX7CDYLCDYL2CDY1; CDY1B
SCHEMBL3058161 0.78 MIF (0.52) IDO1ALDH1A1KMT2ASMN1; SMN2TNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756071-B1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB PHARMA SA (BE) 2009-08-26 EP claimed
US-20070299118-A1 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses UCB, S.A. (BE) 2007-12-27 US claimed
EP-1756071-A1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2007-02-28 EP claimed
WO-2005118561-A1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2005-12-15 WO claimed
US-8293775-B2 Benzoxazolone derivatives, processes for preparing them and their uses UCB PHARMA, S.A. (BE) 2012-10-23 US disclosed
EP-1756071-B1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB PHARMA SA (BE) 2009-08-26 EP disclosed
US-20070299118-A1 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses UCB, S.A. (BE) 2007-12-27 US disclosed
EP-1756071-A1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2007-02-28 EP disclosed
WO-2005118561-A1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299118-A1 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses PARK7, SNCA, GABRA5 HPGD 232/4885IDO1 1662/4885CBX7 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.